u
regul
to
rule
on
pain
drug
u
food
and
drug
regul
will
decid
on
friday
whether
to
recommend
the
sale
of
painkil
that
have
been
link
to
a
high
risk
of
heart
attack
and
stroke
the
food
and
drug
administr
fda
advisori
panel
will
give
it
verdict
after
hear
evid
for
three
day
the
painkil
call
cox
inhibitor
are
sold
under
brand
name
such
a
celebrex
and
vioxx
vioxx
wa
withdrawn
from
shop
last
year
but
merck
said
it
would
consid
sell
it
if
it
get
fda
approv
the
fda
ha
been
ask
to
decid
if
the
benefit
to
patient
justifi
the
increas
risk
put
vioxx
back
on
the
shelf
is
like
to
boost
profit
at
merck
and
make
easier
ani
legal
battl
with
peopl
who
claim
to
have
been
injur
by
the
drug
analyst
said
merck
voluntarili
stop
sale
of
vioxx
on
septemb
a
move
which
caus
the
firm
fourthquart
earn
to
slide
to
bn
â£m
from
bn
a
year
earlier
merck
share
tumbl
more
than
on
the
news
and
the
compani
ha
had
to
set
asid
million
of
dollar
to
cover
the
cost
of
vioxxrel
litig
alarm
bell
were
rung
by
a
research
note
call
approv
which
show
that
the
risk
of
heart
attack
and
stroke
doubl
in
patient
who
had
been
take
the
drug
for
at
least
month
the
cox
inhibitor
were
develop
by
drug
compani
includ
merck
and
pfizer
becaus
they
caus
user
fewer
stomach
problem
than
other
painkil
pfizer
is
still
sell
it
celebrex
and
bextra
product
though
investig
have
suggest
that
they
may
also
be
harm
to
the
heart
merck
announc
of
a
possibl
reintroduct
of
vioxx
caught
analyst
by
surpris
merck
head
of
research
peter
kim
said
that
it
withdrew
vioxx
base
on
the
inform
that
wa
avail
to
u
at
the
time
know
there
were
altern
therapi
he
went
on
to
say
that
thing
have
sinc
chang
in
the
light
of
new
report
given
thi
new
inform
it
is
not
clear
that
the
cardiovascular
risk
observ
in
approv
make
vioxx
uniqu
in
the
class
of
similar
drug
market
in
the
u
mr
kim
explain
on
thursday
david
graham
from
the
fda
offic
of
drug
safeti
told
the
advisori
panel
that
there
realli
doesnt
appear
to
be
a
need
for
cox
inhibitor
accord
to
calcul
present
to
the
u
senat
by
dr
graham
in
novemb
vioxx
may
be
link
to
a
mani
a
to
american
death
face
stem
critic
for
it
handl
of
the
vioxx
case
the
fda
said
on
tuesday
that
it
will
creat
an
independ
bodi
to
overse
the
safeti
of
drug
alreadi
in
the
market
place
european
regul
meanwhil
rule
on
thursday
that
patient
who
have
had
heart
diseas
or
a
stroke
should
not
take
cox
inhibitor
the
european
medicin
agenc
also
said
doctor
should
be
cautiou
about
give
the
drug
to
patient
who
have
risk
factor
for
heart
diseas
